Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Trabectedin vs dacarbazine in Chinese patients with advanced L-type soft tissue sarcoma
CTR20132040Phase 3Completed
- Sponsor
- Ortho Biotech Inc.
- Start
- Apr 2015
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of trabectedin in soft tissue sarcoma (STS), Liposarcoma, leiomyosarcoma (LMS), sponsored by Ortho Biotech Inc.. Started Apr 2015; status: completed.
02
Drugs
trabectedin
03
Conditions
soft tissue sarcoma (STS)Liposarcomaleiomyosarcoma (LMS)
Beyond the preview
Go deeper on CTR20132040.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20132040.